Search Results

Exploring Vascular Pearls and Pitfalls

By Bruce H. Gray, DO, FSCAI, MSVM

Complex Aortic Intervention

By Jason S. Carlson, RT, and Bruce H. Gray, DO

American Board of Vascular Medicine

An update on inaugural testing in the ABVM.

By Bruce H. Gray, DO; Mark A. Creager, MD; and Michael R. Jaff, DO

Board Certification in Vascular and Endovascular Medicine

The emergence of the American Board of Vascular Medicine.

By Bruce H. Gray, DO, Co-Director of the ABVM

Asymptomatic Carotid Stenosis Prior to Coronary Artery Bypass Grafting

Moderator: Bruce H. Gray, DO, FSCAI, MSVM
Panelists: J. Michael Bacharach, MD, MPH, FACC; Eugene M. Langan III, MD; and John Perl II, MD

The Essentials of Ischemic Wound Care

Basic care for ulcerations beyond revascularization.

By Jessica Nevins Morse, MD, and Bruce H. Gray, DO

Platelet Inhibitors: Balancing Art and Science

A case-based look at platelet inhibitors and peripheral arterial intervention.

By Bruce H. Gray, DO, MSVM, FSCAI

One Question… How Will You Apply Drug-eluting Stents in Your SFA Practice?

Featuring Gary M. Ansel, MD; Bruce H. Gray, DO, MSVM, FSCAI; John H. Rundback, MD; and Evan Lipsitz, MD

Prasugrel and Clopidogrel: What Will Their Roles Be?

An editorial on what recent clinical trials have shown us about new antiplatelet agents.

By Bruce H. Gray, DO

The Lower Extremity Grading System

An objective scoring method may help interventionalists select the optimal treatment for patients with peripheral arterial disease.

By BRUCE H. GRAY, DO; SPENCE TAYLOR, MD; AND COREY KALBAUGH, BS

Identifying the Right Diagnosis at the Right Time

An interactive case study intended to emphasize the basics of medical diagnosis.

By Bruce H. Gray, DO, FSCAI, MSVM

Editor's Challenge

A panel of interventional experts weighs in on how they would access and treat a series of challenging access case presentations.
With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark W. Burket, MD; Bruce H. Gray, DO; Craig Walker, MD; and Michael Wholey, MD, MBA

Roundtable Discussion: Paclitaxel in PAD: Where We Stand

A panel discussion on the current state of paclitaxel in peripheral artery disease, including how device use has changed, conversations with patients about safety and informed consent, key lessons learned, and how to move forward.

With Daniel J. Bertges, MD; Theodosios Bisdas, MD; Bruce H. Gray, DO, FSCAI, MSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Sabine Steiner, MD; with additional commentary by Jos C. van den Berg, MD, PhD

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

The Venous Challenge

By Barry T. Katzen, MD

The Battle Against CLI

By John R. Laird Jr, MD, Chief Medical Editor

Challenge Accepted

By John A. Kaufman, MD